Event Details

January 01, 2017

Description

Military Chemical and Pharmaceutical Plant (MCPP) received license to cultivate medical cannabis.

Participants (1)

Name Type Mentions
MCPP person 0 View Entity

Source Documents (1)

HOUSE_OVERSIGHT_024897.jpg

Market Research Report / Financial Analysis • 2.09 MB
View

This document is page 81 of a Cowen Collaborative Insights market research report dated February 25, 2019, discussing the regulatory landscape for medical cannabis and CBD in Europe, specifically the UK and Italy. It details the legalization history, licensing requirements involving agencies like the MHRA and FSA, and market activities of companies like GW Pharmaceuticals, Tilray, Bedrocan, Canopy, and Aurora. The document bears a 'HOUSE_OVERSIGHT_024897' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.

Event Metadata

Type
Unknown
Location
Italy
Significance Score
5/10
Participants
1
Source Documents
1
Extracted
2025-11-19 22:39

Additional Data

Source
HOUSE_OVERSIGHT_024897.jpg
Date String
2017

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein event